Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Lupus Health Center

Font Size

New Lupus Drug Benlysta Approved

First New Lupus Drug in 56 Years; Reduces Lupus Activity, May Cut Steroid Need
WebMD Health News
Reviewed by Laura J. Martin, MD

March 9, 2011 -- The FDA has approved Benlysta, the first new lupus drug since 1955.

Benlysta is approved for the treatment of patients with active, autoantibody-positive lupus who are getting standard therapy. Standard therapy includes corticosteroids, antimalarial drugs, immunosuppressive agents, and NSAID anti-inflammatory drugs.

As many as 1.5 million Americans have systemic lupus erythematosus (SLE), commonly called lupus. Lupus is an autoimmune disease in which a particular type of white blood cell -- B lymphocytes -- turn the body's immune defenses against the body's own cells.

Benlysta inhibits the maturation of these B cells. Because B cells are crucial elements of the immune system, Benlysta carries serious risks. There were more deaths and serious infections among patients taking Benlysta than among patients taking placebo.

The drug may work best for patients with moderate disease, says lupus expert Eric L. Greidinger, MD, chief of rheumatology and immunology at the University of Miami Miller School of Medicine.

"The hope is that Benlysta may allow some of these patients who have persistently active lupus who are using substantial doses of steroids to bring their disease under better control, so they have less lupus activity and can take less steroids, exposing them to fewer of the many steroid-associated side effects," Greidinger tells WebMD.

Lupus is particularly common among African-American women. In clinical trials, African-American patients did not appear to respond to Benlysta as well as other patients -- so the manufacturer, Human Genome Sciences, has agreed to conduct a new study of the drug in this subgroup of patients.

For more information about Benlysta, see WebMD's FAQ.

Today on WebMD

grocery shopping list
And the memory problems that may come with it.
Lupus rash on nails
A detailed, visual guide.
sunburst filtering through leaves
You might be extra sensitive to UV light. Read on.
fruit drinks
For better focus in your life.
Woman rubbing shoulder
Bag of cosmetics
young woman hiding face
pregnant woman
5 Lupus Risk Factors
Young adult couple
doctor advising patient
sticky notes on face

WebMD Special Sections